News & Press

Dr. Yao-chang Xu Attends the Hong Kong Biotech Summit 2018

Mar 23,2018
By Abbisko
Back

On March 22, Dr. Yao-chang Xu, CEO of Abbisko, attended the first Hong Kong Biotech Summit 2018 held by HKEX, when HKEX was revising its listing rules for biotech companies. As a representative of innovative platform-based biotech companies, Abbisko participates in and actively watches the impacts of the rule changes on life science companies and the trends in the industry’s future development.

Tel:(+86) 021-68912098

E-Mail:Public@abbisko.com Bd@abbisko.com

Copyright © 2021 All rights reserved:Abbisko Therapeautics     沪ICP备17056565号-1